Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NHS Announces £127m Maternity Boost for Patients and Families
The NHS in England has today announced a £127 million funding boost for maternity services across […]
NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer
A targeted new drug for a rare and aggressive form of lung cancer will be […]
Hundreds of Patients to Benefit From Revolutionary Lung Cancer Drug On The NHS
A revolutionary targeted drug for lung cancer will be made available to anyone who is […]
Health and Social Care Secretary Takes Reform Agenda on the Road
Health and Social Care Secretary Sajid Javid will be on the ‘road to recovery’ this […]
NHS Vaccination Lead Comments On Boosters Preventing An Estimated 105,000 Hospitalisations
Commenting on analysis published by the UKHSA today estimating that over 105,000 hospitalisations in people […]
NHS Publishes Electives Recovery Plan To Boost Capacity And Give Power To Patients
The NHS and government have today set out a blueprint to address backlogs built up during the Covid […]
SBRI Healthcare Awards £1 Million to Pioneering Innovations to Support the Delivery of a Net Zero NHS
SBRI Healthcare has awarded a total of £1 million to ten pioneering MedTech and Digital […]
England to Return to Plan A Following the Success of the Booster Programme
The government has today announced that England will fully return to Plan A on Thursday […]
New Breast and Lung Cancer Treatments Approved in Scotland
3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for […]
NHS Launches Landmark Mental Health Campaign With ‘Help!’ From The Beatles
Today, the NHS will launch a new landmark campaign using the iconic Beatles song ‘Help!” […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more